Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacDougall

Showing results (261-270 of 373) with videos related to

Pageof 38
Sort By:
Transplantation|April 28, 2006
Posttransplantation anemia in adult renal allograft recipients: prevalence and predictorsNilesh Shah, Salam Al-Khoury, Behdad Afzali, et al.
Journal of Pain and Symptom Management|October 17, 2020
Feasibility Trial of Cognitive Behavioral Therapy for Fatigue in Hemodialysis (BReF Intervention)Federica Picariello, Rona Moss-Morris, Sam Norton, et al.
BMJ Open|March 11, 2018
Cognitive-behavioural therapy (CBT) for renal fatigue (BReF): a feasibility randomised-controlled trial of CBT for the management of fatigue in haemodialysis (HD) patientsFederica Picariello, Rona Moss-Morris, Iain C Macdougall, et al.
American Journal of Hematology|July 18, 2018
A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia"William E Strauss, N Franklin Adkinson, Iain C Macdougall, et al.
Current Medical Research and Opinion|September 21, 2010
Value of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE studyFrancesco Locatelli, Kai-Uwe Eckardt, Iain C Macdougall, et al.
Transplantation Proceedings|February 5, 2013
Hemojuvelin and iron metabolism in kidney and heart allograft recipientsP Przybylowski, E Koc-Zorawska, I Glowinska, et al.
American Journal of Therapeutics|September 1, 2018
Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" FrameworkSony Jacob, Judy Nichols, Iain C Macdougall, et al.
Current Medical Research and Opinion|May 11, 2006
Iron and the anaemia of chronic disease: a review and strategic recommendationsIvor Cavill, Michael Auerbach, George R Bailie, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Detection of functional iron deficiency during erythropoietin treatment: a new approachI C Macdougall, I Cavill, B Hulme, et al.
Nephrology (Carlton, Vic.)|October 5, 2016
Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysisSimon D Roger, Martin Tio, Hyeong-Cheon Park, et al.
Pageof 38

Showing results (261-270 of 373) with videos related to

Sort By:
Pageof 38
Transplantation|April 28, 2006
Posttransplantation anemia in adult renal allograft recipients: prevalence and predictorsNilesh Shah, Salam Al-Khoury, Behdad Afzali, et al.
Journal of Pain and Symptom Management|October 17, 2020
Feasibility Trial of Cognitive Behavioral Therapy for Fatigue in Hemodialysis (BReF Intervention)Federica Picariello, Rona Moss-Morris, Sam Norton, et al.
BMJ Open|March 11, 2018
Cognitive-behavioural therapy (CBT) for renal fatigue (BReF): a feasibility randomised-controlled trial of CBT for the management of fatigue in haemodialysis (HD) patientsFederica Picariello, Rona Moss-Morris, Iain C Macdougall, et al.
American Journal of Hematology|July 18, 2018
A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia"William E Strauss, N Franklin Adkinson, Iain C Macdougall, et al.
Current Medical Research and Opinion|September 21, 2010
Value of N-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE studyFrancesco Locatelli, Kai-Uwe Eckardt, Iain C Macdougall, et al.
Transplantation Proceedings|February 5, 2013
Hemojuvelin and iron metabolism in kidney and heart allograft recipientsP Przybylowski, E Koc-Zorawska, I Glowinska, et al.
American Journal of Therapeutics|September 1, 2018
Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" FrameworkSony Jacob, Judy Nichols, Iain C Macdougall, et al.
Current Medical Research and Opinion|May 11, 2006
Iron and the anaemia of chronic disease: a review and strategic recommendationsIvor Cavill, Michael Auerbach, George R Bailie, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Detection of functional iron deficiency during erythropoietin treatment: a new approachI C Macdougall, I Cavill, B Hulme, et al.
Nephrology (Carlton, Vic.)|October 5, 2016
Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysisSimon D Roger, Martin Tio, Hyeong-Cheon Park, et al.
Pageof 38